Drugs

, Volume 22, Issue 5, pp 415–420 | Cite as

Drug Literature Abstracts

Article
  • 5 Downloads

Keywords

Breast Cancer Risk Streptokinase Prazosin Diabetic Ketoacidosis Vidarabine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Editorial: Lancet 1: 1035 (1981).Google Scholar

Reference

  1. Field, H.J. and Wildy, P.: British Medical Journal 282: 1821 (1981).PubMedCrossRefGoogle Scholar

Reference

  1. Kaplan, N.M.; American Heart Journal 101: 867 (1981).PubMedCrossRefGoogle Scholar

Reference

  1. Carmichael, J. et al. British Medical Journal 282: 1419 (1981).PubMedCrossRefGoogle Scholar

References

  1. Royal College of General Practitioners: British Medical Journal 282: 2089 (1981).CrossRefGoogle Scholar
  2. Vessey, M.P. et al.: British Medical Journal 282: 2093 (1981).PubMedCrossRefGoogle Scholar
  3. Editorial: British Medical Journal 282: 2075 (1981).Google Scholar
  4. Pike, M.C. et al.: British Journal of Cancer 43: 72 (1981).PubMedCrossRefGoogle Scholar

Reference

  1. Levine, S.N. and Loewenstine, J.E.: Archives of Internal Medicine 141: 713–715 (1981).PubMedCrossRefGoogle Scholar

Reference

  1. Editorial: Lancet 1: 1350 (1981).Google Scholar

Copyright information

© ADIS Press Australasia Pty Ltd 1981

Personalised recommendations